Orange


Full-year EBITDAaL growth target once again raised

27/10/26 -"Orange reported robust Q3 results at the upper end of expectations, consistent with the solid H1 trend. The Group’s 2026 EBITDAaL growth guidance, raised from c.3% to above 3% after Q1 and to above ..."

Pages
56
Language
English
Published on
27/10/26
You may also be interested by these reports :
27/10/26
Orange reported robust Q3 results at the upper end of expectations, consistent with the solid H1 trend. The Group’s 2026 EBITDAaL growth guidance, ...

22/10/26
Q2 results exceeded expectations, prompting an upward revision of the 2026 outlook. EBITDA growth is now projected at 3%-4%, up from the previous 3%. ...

21/10/26
In Q3, revenue remained stable compared to the previous year, with a slight improvement over H1. However, concerns arise from EBITDA, which ...

21/10/26
Q3 results reached the upper end of the consensus range. Management has revised the guidance for total revenue growth upwards. However, Capex is now ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO